The political reaction to France’s ban on nicotine pouches has now taken a decisive turn. What began as concern over proportionality and internal market implications has evolved into coordinated political action at the highest EU level.
According to reporting in Aftonbladet, the entire Swedish S&D delegation, including MEP Johan Danielsson S&D, has formally intervened. In two parallel letters addressed to Roberta Metsola and Ursula von der Leyen, the delegation raises serious concerns about the French measure and its wider implications.
From concern to coordinated action
The letter to the Parliament is particularly striking. It calls for the suspension of Strasbourg part sessions if France proceeds with a ban on nicotine pouches and a criminalisation of possession that, in the delegation’s view, fundamentally undermines proportionality and legal certainty within the Union.
The argument is not limited to the free movement of goods. The delegation explicitly highlights the implications for free movement of persons, noting that EU citizens could face severe criminal penalties simply for possessing a product that is legal in their home Member State. Reported sanctions include up to five years’ imprisonment and substantial fines.
This is framed not as a marginal regulatory issue, but as a direct challenge to core internal market principles.
A challenge to evidence-based policymaking
In their parallel letter to the Commission, the Swedish S&D MEPs go further. They question whether the French approach can be considered proportionate at all, and explicitly ask on what scientific basis such a conclusion could be reached.
The delegation points to a key reality often absent from the broader EU debate. In Sweden, a significant number of adults have transitioned from cigarettes to smoke-free nicotine products, including pouches, thereby reducing exposure to the harms associated with combustion.
The implication is clear. Measures that eliminate or severely restrict such alternatives must meet a high evidentiary threshold. Without it, they risk being not only ineffective, but counterproductive.
The Swedish precedent: strict but purposeful
This position is consistent with Sweden’s own regulatory trajectory. The former Social Democratic government did not leave nicotine pouches unregulated. On the contrary, it introduced a framework that is both strict and targeted, with clear limits on marketing and product design.
At the same time, access for adult consumers was preserved.
Pouchforum considers this approach a model worth noting. It reflects a balance between two objectives that are too often treated as mutually exclusive: protecting young people and maintaining viable alternatives for adult smokers.
Letting outcomes guide policy
Sweden’s broader public health outcomes reinforce this logic. By maintaining access to affordable, low risk alternatives, policymakers have enabled smokers to move away from cigarettes. The shift has been driven by consumer choice, not prohibition.
This stands in contrast to approaches that prioritise restriction over substitution. Removing alternatives does not eliminate nicotine use. It risks entrenching the most harmful forms of consumption.
A political inflection point
What makes the current moment significant is not only the substance of the French measure, but the breadth of the response.
The fact that the entire Swedish S&D delegation has signed both letters signals a shift. This is no longer a cautious, technical engagement. It is a coordinated political stance that challenges both the proportionality of national measures and the role of EU institutions in responding to them.
Combined with comments from the Swedish government, this suggests that Swedish politics, even if differing in methods, is converging on a common position. Across party lines, there is growing willingness to push back against what are seen as populist and disproportionate restrictions on low risk products.
From national dispute to European test case
The call to suspend Strasbourg sessions is, in itself, an extraordinary step. Whether or not it is implemented, it sends a clear signal.
The regulation of nicotine pouches is no longer a niche issue. It is becoming a test case for how the EU balances public health objectives with internal market principles, scientific evidence, and real world outcomes.
The Swedish intervention makes one thing clear. The debate is entering a new phase, where the question is no longer whether to regulate, but how to do so without undermining the very goals such regulation is meant to achieve.